Skip to main content
SpringerLink
Log in

Primäre Prävention, Chemoprävention

  • Chapter
Geriatrische Onkologie

Zusammenfassung

Es ist ein alter Traum der Menschheit, Krankheiten, insbesondere die des alternden Menschen, zu verhüten statt sie heilen zu müssen. Archetypus-ähnlich zieht sich der Gedanke durch die Geschichte des Heilens, dass die Ursachen für Krankheit im Verlassen einer naturphilosophischen oder monotheistischen Ordnung des Individuums liegen. Rituale Handlungen und Fürbitten waren über Tausende von Jahren die ästhetischen Zeichen von Individuen oder sozialen Lebensgemeinschaften, nicht aus diesen heilbringenden Ordnungen verstoßen zu werden. Die vier apokalyptischen Reiter — Hunger, Krieg, Krankheit und Tod — holten den so aus der Ordnung gefallenen alternden Menschen gleichsam ein und bestimmten über sein Schicksal.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ahn HY, Hadizadeh KR, Seul C, Yun YP, Vetter H, Sachinidis A (1999) Epigallocathecin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol Biol Cell 10: 1093–1104

    PubMed  CAS  Google Scholar 

  • Beuth J, Bock PR, Hanisch J (1999) Efficacy of additional oral enzyme treatment in breast cancer patients. Abstr. Commun. ECCO-Meeting, Vienna. Mucos, Geretsried

    Google Scholar 

  • Der Weltgesundheitsbericht (1997) Bericht des Generaldirektors/World Health Organization. Deutsches Grünes Kreuz, Marburg

    Google Scholar 

  • Doll R, Peto R (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66: 1191–1208

    PubMed  CAS  Google Scholar 

  • Fujiki H (1999) Two stages of cancer prevention with green tea. J Cancer Res Clin Oncol 125: 589–597

    Article  PubMed  CAS  Google Scholar 

  • Geiler G, Höffken K, Schmoll H-J (Hrsg) (1998) Onkologie 2000. Schnittpunkte zwischen Grundlagenforschung und Klinik. Nova Acta Leopoldina, N. F., Nr. 305, Bd 78

    Google Scholar 

  • Imai K, Suga K, Nakachi K (1997) Cancer-preventive effects of drinking green tea among a Japanese population. Br Med J 26: 769–775

    CAS  Google Scholar 

  • Kleef R, Delohery TM, Bovbjerk DH (1996) Selective modulation of cell adhesion molecules on lymphocytes by bromelain protease 5. Clin Exp Pathobiol 64: 339–346

    Article  CAS  Google Scholar 

  • Kolac C, Streichhan P, Lehr CM (1996) Oral bioavailibility of proteolytic enzymes. Eur J Pharm Biopharm 42: 222–232

    CAS  Google Scholar 

  • Lehmann PV (1996). Immunomodulation by proteolytic enzymes. Nephrol Dialysis Transplant 11: 953–955

    Article  Google Scholar 

  • Lü H, Niggemann B, Zänker KS (1999) Genistein interferes with the locomotory machinery of tumor cells — a promosing candidate for a chemopreventive agent. Cancer Lett 143(1): 33

    Google Scholar 

  • Margetts G, Barber K, Christie RB, Jones WE, Bowden WT (1972) Changes in serum trypsin inhibitors induced by the administration of protelytic enzyme tablets to surgical patients. Br J Clin Pract 26: 293–298

    PubMed  CAS  Google Scholar 

  • Miller JM, Williard RF, Polacheck AA (1960) An investigation of trypsin-J131 in patients. Exp Med Surg 18: 352–370

    PubMed  CAS  Google Scholar 

  • Nakachi K, Imai K, Suga K (1997) Epidemiological evidence for prevention of cancer and cardiovascular disease by drinking green tea. In: Ohigashi H, Osawa T, Terao J, Watanaba S, Yoshikawa T (eds) Food factors for cancer prevention. Springer Tokyo, pp 105–108

    Google Scholar 

  • Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y (1998) Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 89: 254–261

    Article  PubMed  CAS  Google Scholar 

  • Orphan Drug Approval for WobeMugosE by Dept. of Health & Human Services (1998) Office of Orphan Products Development, FDA, Rockville, MD, USA

    Google Scholar 

  • Parkin DM (1999) Epidemiology of cancer in southeast Asia. Cancer Lett 143(1): 36–37

    Google Scholar 

  • Popiela T, Kulig A, Bock PR, Hanisch J (1999) Influence of an additional treatment with oral enzymes on patients with colorectal cancers. Abstr. Commun. ECCO-Meeting, Vienna. Mucos, Geretsried

    Google Scholar 

  • Sakalova A, Dedik L, Gazova S, Hanisch J, Schieß W (1998) Survival analysis of an adjuvant therapy with oral enzymes in multiple myeloma patients. Br J Haemat 102: 353

    Google Scholar 

  • Sporn MB, Dunlop NM, Newton DL, Smith JM (1976) Prevention of chemical carcinogenesis by vitamine A and its synthetic analogs (retinoids) Fed Proc 35: 1332–1338

    PubMed  CAS  Google Scholar 

  • Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E, Fujiki H (1999) Essential role of tumor necrosis factor-alpha in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res 59: 4516–4518

    PubMed  CAS  Google Scholar 

  • Sy MS, Liu D, Kogerman P, Culp LA (1997) Potential of targeting cell surface CD44 proteins with proteinases in preventing tumor growth and metastasis. Int J Immunther 13: 105–109

    CAS  Google Scholar 

  • Uhlenhuth K (1900) Neuer Beitrag zum spezifischen Nachweis von Eiereiweiss auf biologischem Wege. Dtsch Med Wochenschr 46: 733–7345

    Google Scholar 

  • Vogelstein B, Fearon ER, Hamilton SR et al. (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525–532

    Article  PubMed  CAS  Google Scholar 

  • Wald M, Zavadova E, Pouckova P, Zadinova M, Boubelik M (1998a) Polyenzyme preparation Wobe-Mugos inhibits growth of solid tumors and development of experimental metastases in mice. Life Sci 62: 43–48

    Google Scholar 

  • Wald M, Olejar T, Zadinova M, Pouckova P (1998b) Proteinases reduce metastatic dissemination and increase survival time in C57B16 mice with the Lewis lung carcinoma. Life Sci 63: 237–243

    Article  Google Scholar 

  • Zänker KS (1997) Zellkommunikation und die Theorie morphischer Felder. In: Dürr H-P, Gottwald F-T (Hrsg) Rupert Sheldrake in der Diskussion. Das Wagnis einer neuen Wissenschaft des Lebens. Scherz, Bern, München Wien, S 60–77

    Google Scholar 

  • Zänker KS (1998) Klinische Interventionsstudien zur Chemoprävention. Vom Rationale zu Ergebnissen. Onkologe 4: 716–722

    Google Scholar 

  • Zänker KS (1999a) Chemoprävention der Karzinogenese. In: Schmoll J-J, Höffken K, Possinger K (Hrsg) Kompendium Internistische Onkologie. Springer, Berlin Heidelberg New York, S 265–284

    Google Scholar 

  • Zänker KS (1999b) Chemoprevention of cancer for the next millenium — quo vadis? Cancer Lett 143(1): 7–11

    Article  Google Scholar 

Download references

Authors
  1. K. S. Zänker
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Innere Medizin II, Friedrich-Schiller-Universität Jena, Erlanger Allee 101, D-07747, Jena, Germany

    Klaus Höffken  & Ulrich Wedding  & 

  2. St. Bonifatius-Hospital, Wilhelmstraße 3, D-49808, Lingen, Germany

    Gerald Kolb

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Zänker, K.S. (2002). Primäre Prävention, Chemoprävention. In: Höffken, K., Wedding, U., Kolb, G. (eds) Geriatrische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56391-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56391-1_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63154-2

  • Online ISBN: 978-3-642-56391-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation